Locally Advanced Rectal Cancer Clinical Trial
Official title:
A Prospective Phase II Trial of Short-course Radiotherapy Based Total Neoadjuvant Therapy Combined With PD-1 Inhibitor for Locally Advanced Rectal Cancer (TORCH）
TORCH is a prospective, multicentre, randomized phase II trial. 130 LARC (T3-4/N+M0, distance from anal verge ≤12cm) patients will be treated with total neoadjuvant therapy (TNT) and assigned to Group A and Group B. Group A receives SCRT (25Gy/5Fx) followed by 6 cycles of Toripalimab combined with CAPOX (ToriCAPOX). Group B receives 2 cycles of ToriCAPOX followed by SCRT and 4 cycles of ToriCAPOX. TME surgery is scheduled after TNT while a watch and wait (W&W) option can be applied to patients achieving clinical complete response (cCR). The primary endpoint is complete response (CR, pathological complete response [pCR] plus cCR) rate. The secondary endpoints include the grade 3-4 acute adverse effects (AE) rate, 3-year DFS rate, etc.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05079438 -
Dendrobium Huoshanense Suppository in Rectal Cancer
|
Phase 3 | |
| Recruiting |
NCT02964468 -
Dose-escalation Trial of Preoperative Radiotherapy and Concurrent Chemotherapy in Locally Advanced Rectal Cancer
|
N/A | |
| Not yet recruiting |
NCT05507112 -
TIME in Immunotherapy Combined With nCRT for Rectal Cancer
|
Phase 2 | |
| Not yet recruiting |
NCT05998122 -
Total Neoadjuvant Chemoradiotherapy Plus Anti-PD-1 in Subperitoneal Patients With Locally Advanced Rectal CancerPatients With Locally Advanced Rectal Cancer: A Prospective, Single Arm, Exploratory Study
|
Phase 2 | |
| Completed |
NCT04324567 -
Inflammation After Laparoscopic Robot-assisted Surgery for Locally Advanced Rectal Cancer
|
||
| Recruiting |
NCT05412082 -
SMART TNT for the Conservative Management of Locally Advanced Rectal Cancer
|
Phase 1 | |
| Recruiting |
NCT05980689 -
Combination of AK104 and Neoadjuvant Chemoradiotherapy in pMMR/MSS Locally Advanced Rectal Cancer
|
Phase 2 | |
| Recruiting |
NCT02605265 -
Trial of Capecitabine With or Without Irinotecan Driven by UGT1A1
|
Phase 3 | |
| Terminated |
NCT02151019 -
Pre-operative 3-DCRT vs IMRT for Locally Advanced Rectal Cancer
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05086627 -
Short-course Radiotherapy Followed by Tislelizumab + CapeOX in the Treatment for Locally Advanced Rectal Cancer
|
Phase 2 | |
| Not yet recruiting |
NCT05076305 -
PelvEx 4: Advanced Pelvic Malignancy and the Role of the Multi-disciplinary Team Meeting
|
||
| Recruiting |
NCT03824899 -
UGT1A1 Combined With Pharmacokinetics of SN-38 in CPT-11-based CRT in Patients With Advanced Rectal Cancer
|
N/A | |
| Recruiting |
NCT05845268 -
Total Neoadjuvant Therapy Combined With Tislelizumab for Local Advanced of Middle and Low Rectal Cancer
|
Phase 2 | |
| Completed |
NCT03392584 -
Detection and Inflammatory Characterization of Deep Infection After Surgery for Locally Advanced Rectal Cancer With Microdialysis Catheters
|
||
| Terminated |
NCT04177602 -
Evaluating Trifluridine/Tipiracil Based Chemoradiation in Locally Advanced Rectal Cancer - The Phase I/II TARC Trial
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05646511 -
Total Neoadjuvant Therapy of SCRT+CAPOX vs SCRT+CAPOXIRI for Locally Advanced Rectal Cancer (ENSEMBLE)
|
Phase 3 | |
| Terminated |
NCT02290574 -
Efficacy of NeoThermo-Radio-chemotherapy for LA Rectal Cancer Before Laparoscopic TME: Prospective Phase II Trial
|
N/A | |
| Recruiting |
NCT03702985 -
Radiation-protection Effect of Amifostine in Locally Advanced Rectal Cancer
|
Phase 2 | |
| Active, not recruiting |
NCT05877352 -
Intraoperative Electron Radiotherapy in Rectal Cancer - A Feasibility Trial
|
N/A | |
| Not yet recruiting |
NCT06375434 -
Correlation Between Gut Microbiota and Radiosensitivity of Rectal Cancer
|